longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AI Infrastructure Expands as Capital Rotates Across 10 Key US Equities

Global Report
Sep 1, 2026 at 09:18 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Driven by AI compute deployments and energy market swings, institutional capital is rapidly concentrating on tangible infrastructure providers. Vertiv and Hubbell showcased strong earnings this quarter, while select biotech and energy names face operational headwinds amid ongoing sector divergence.

The intersection of expanding AI infrastructure and fluctuating energy markets has triggered a structural re-rating across multiple equity sectors. As of the second half of 2026, institutional flows are increasingly concentrating on firms providing core technical and physical infrastructure, according to analysts tracking cross-market capital movements.

Vertiv (VRTL.US) & Hubbell (HUBB.US)

Vertiv has rallied significantly this year, consistently outperforming its peers in the data center supply chain. The company raised its full-year forecast after reporting Q2 2026 net sales of USD 3.27 billion, up 24% year-over-year. According to people familiar with the matter, demand for its high-density IT cooling and power deployments is running at near capacity globally. Similarly benefiting from utility upgrades, Hubbell posted Q2 2026 revenue of USD 1.71 billion and an adjusted EPS of USD 5.52, which topped estimates, further bolstered by its USD 3 billion strategic acquisition of NSI Industries.

Mobileye Global (MBLY.US) & Taoping (TAOP.US)

Mobileye Global shares have seen a pullback recently, despite generating USD 1.65 billion in revenue for 2024, as operating losses weigh heavily on sentiment. The company is targeting broader autonomous vehicle deployments, having recently deepened its mass-production partnership with Volkswagen and set plans to integrate driverless tech with Lyft by 2026. Meanwhile, Taoping has faced year-to-date pressure but showed pockets of operational recovery. In April 2026, the firm secured over USD 3 million in new smart elevator orders and terminated non-core acquisitions to prioritize higher-return IoT opportunities.

PBF Energy (PBF.US) & Invesco Optimum Yield ETF (PDBC.US)

On the energy front, PBF Energy has underperformed this year. Despite running its Martinez refinery at reduced capacity due to operational hurdles, the company managed USD 1.27 billion in operating income for Q2 2026 and declared a USD 0.275 per share dividend. Tracking similar commodity volatility, the Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF has rebounded recently. As crude and natural gas futures experienced wide swings in 2026, the ETF's active strategy helped mitigate some negative roll yield risks.

VBI Vaccines (VBIO.US) & Genetron Holdings (GENB.US)

In the biotech space, VBI Vaccines slumped this month, following its early 2025 restructuring and subsequent acquisition by K2 VBI Trust. While its PreHevbrio vaccine saw a 105% revenue jump in Q1 2024, its independent trajectory remains closed. Genetron Holdings completed its privatization in 2024 with a merger consideration of USD 4.08 per ADS, concluding its tenure in the public markets.

Rumble (RUM.US) & Netlist (NLST.US)

Rumble and Netlist have exhibited diverging price actions over the last month. Rumble is aggressively targeting independent content creators to challenge legacy platforms, while Netlist continues to monetize its high-performance memory products and intellectual property portfolio, capitalizing on the robust data center hardware demand in 2026.

Market attention is now shifting toward the upcoming Q3 2026 capital expenditure reports. If hardware investments continue at this pace, institutional managers could accelerate the rotation out of speculative software into tangible equipment providers.

This article does not constitute investment advice.

Login to unlock2,900characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Jul 11, 2025 at 02:58 AMTrack Hyper | Intel sells Mobileye shares: What is the impact on muscle tissue?

Related Stocks

Valion Bio

Valion Bio

USVBIO

+9.64%

Mobileye Global

Mobileye Global

USMBLY

-0.91%

RUM

RUM

USRUM

-7.70%

LongbridgeAI